Transcriptional regulation of RKIP expression by androgen in prostate cells

Cellular Physiology and Biochemistry

Volumn 30, Issue 6, 2012, Pages 1340-1350

  Zhang, Honglai ^a   Wu, Jianguo ^b   Keller, Jill M ^a   Yeung, Kam ^c   Keller, Evan T ^a   Fu, Zheng ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Androgen; Androgen receptor; Prostate; RKIP

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BICALUTAMIDE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CASTRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPITHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SUPPRESSOR GENE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

MUS;

EID: 84867662728     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343323     Document Type: Article

References (43)

1. Simister P, Banfield M, Brady R: The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. Acta Crystallogr D Biol Crystallogr 2002;58:1077-1080. (Pubitemid 34653050)
2. Banfield M, Barker J, Perry A, Brady R: Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure 1998;6:1245-1254. (Pubitemid 28485957)
3. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis K, Rose D, Mischak H, Sedivy JM, Kolch W: Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999;401:173-177. (Pubitemid 29436321)
4. Bernier I, Jollès P: Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. Biochim Biophys Acta 1984;790:174-181. (Pubitemid 15206863)
5. Perry A, Hall L, Bell A, Jones R: Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions. Biochem J 1994;301:235-242. (Pubitemid 24214706)
6. Tohdoh N, Tojo S, Agui H, Ojika K: Sequence homology of rat and human HCNP precursor proteins, bovine phosphatidylethanolamine-binding protein and rat 23-kDa protein associated with the opioid-binding protein. Brain Res Mol Brain Res 1995;30:381-384.
7. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, Garcia JJ, Scott L, Fyfe N, Murray GI, Kolch W: Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006;24:5672-5679. (Pubitemid 46631308)
8. Bollengier F, Mahler A: Localization of the novel neuropolypeptide h3 in subsets of tissues from different species. J Neurochem 1988;50:1210-1214.
9. Frayne J, Ingram C, Love S, Hall L: Localisation of phosphatidylethanolamine-binding protein in the brain and other tissues of the rat. Cell Tissue Res 1999;298:415-423.
10. Moffit JS, Boekelheide K, Sedivy JM, Klysik J: Mice lacking Raf kinase inhibitor protein-1 (RKIP-1) have altered sperm capacitation and reduced reproduction rates with a normal response to testicular injury. J Androl 2007;28:883-890. (Pubitemid 350058139)
11. Ojika K, Mitake S, Tohdoh N, Appel S, Otsuka Y, Katada E, Matsukawa N: Hippocampal cholinergic neurostimulating peptides (HCNP). Prog Neurobiol 2000;60:37-83. (Pubitemid 30001451)
12. Vallee BS, Tauc P, Brochon JC, Maget-Dana R, Lelievre D, Metz-Boutigue MH, Bureaud N, Schoentgen F: Behaviour of bovine phosphatidylethanolamine- binding protein with model membranes. Evidence of affinity for negatively charged membranes. Eur J Biochem 2001;268:5831-5841. (Pubitemid 33079318)
13. Yeung K, Janosch P, McFerran B, Rose D, Mischak H, Sedivy J, Kolch W: Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 2000;20:3079-3085. (Pubitemid 30215020)
14. Yeung K, Rose D, Dhillon A, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy J: Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 2001;21:7207-7217. (Pubitemid 32953475)
15. Lorenz K, Lohse MJ, Quitterer U: Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003;426:574-579. (Pubitemid 37522645)
16. Al-Mulla F, Bitar MS, Al-Maghrebi M, Behbehani AI, Al-Ali W, Rath O, Doyle B, Tan KY, Pitt A, Kolch W: Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3beta. Cancer Res 2011;71:1334-1343.
17. Al-Mulla F, Bitar MS, Feng J, Park S, Yeung KC: A new model for raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One 2012;7:e29532.
18. Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller P, Mizokami A, Dunn R, Chinnaiyan A, Yao Z, Keller ET: Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006;66:248-256. (Pubitemid 43191224)
19. Fu Z, Smith P, Zhang L, Rubin M, Dunn R, Yao Z, Keller E: Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003;95:878-889. (Pubitemid 36833879)
20. Lamont KR, Tindall DJ: Androgen regulation of gene expression. Adv Cancer Res 2010;107:137-162.
21. Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC: Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 2008;27:2243-2248. (Pubitemid 351483382)
22. Hellman LM, Fried MG: Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. Nat Protoc 2007;2:1849-1861. (Pubitemid 47308124)
23. Shang Y, Hu X, Di Renzo J, Lazar MA, Brown M: Cofactor dynamics and sufficiency in estrogen receptorregulated transcription. Cell 2000;103:843-852.
24. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, Liang J, Sun L, Yang X, Shi L, Li R, Li Y, Zhang Y, Li Q, Yi X, Shang Y: LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009;138:660-672.
25. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS: Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997;18:1215-1223. (Pubitemid 28132513)
26. Bonsing BA, Devilee P, Cleton-Jansen AM, Kuipers-Dijkshoorn N, Fleuren GJ, Cornelisse CJ: Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast cancinomas. Cancer Res 1993;53:3804-3811. (Pubitemid 23252047)
27. Cleutjens K, Van Eekelen C, Van der Korput H, Brinkmann A, Trapman J: Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 1996;271:6379-6388. (Pubitemid 26095448)
28. Roche P, Hoare S, Parker M: A consensus DNA-binding site for the androgen receptor. Mol Endocrinol 1992;6:2229-2235. (Pubitemid 23021573)
29. Zeng L, Imamoto A, Rosner MR: Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 2008;12:1275-1287.
30. Prins G: Molecular biology of the androgen receptor. Mayo Clin Proc 2000;75:S32-35.
31. Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C: Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. J Biol Regul Homeost Agents 2001;15:123-129. (Pubitemid 32717548)
32. Mendelsohn LG: Prostate cancer and the androgen receptor: strategies for the development of novel therapeutics. Prog Drug Res 2000;55:213-233.
33. Perry JE, Tindall DJ: Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP. Cancer Res 1996;56:1539-1544. (Pubitemid 26104016)
34. Kousteni S, Bellido T, Plotkin L, O'Brien C, Bodenner D, Han L, Han K, Di Gregorio G, Katzenellenbogen J, Katzenellenbogen B, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC: Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104:719-730. (Pubitemid 32241022)
35. Swinnen J, Ulrix W, Heyns W, Verhoeven G: Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 1997;94:12975-12980. (Pubitemid 27518461)
36. Denis L, Murphy G: Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer 1993;72:3888-3895. (Pubitemid 23361549)
37. Koivisto P, Kolmer M, Visakorpi T, Kallioniemi O: Androgen receptor gene and hormonal therapy failure of prostate cancer. Am J Pathol 1998;152:1-9. (Pubitemid 28028039)
38. Al-Mulla F, Hagan S, Al-Ali W, Jacob S P, Behbehani AI, Bitar MS, Dallol A, Kolch W: Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 2008;61:524-529. (Pubitemid 351518239)
39. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A: Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 2007;127:820-827.
40. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass JR: Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006;55:1467-1474. (Pubitemid 44476793)
41. Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, Li X, Shen H, Wang X: MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun 2012;425:127-133.
42. Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, Daignault S, Al-Mulla F, Keller E, Bonavida B, De La Serna I, Yeung KC: Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 2012;72:3091-3104.
43. Singhal J, Nagaprashantha LD, Vatsyayan R, Ashutosh, Awasthi S, Singhal SS: Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma. Cancer Prev Res (Phila) 2012;5:473-483.